Clearpoint Neuro, Inc. (CLPT)
NASDAQ:CLPT
Want to see CLPT full AI Analyst Report?
CLPT Stock Chart & Stats
$27.32
-$0.35(-2.27%)
At close: 4:00 PM EST
$27.32
-$0.35(-2.27%)
Day’s Range― - ―
52-Week Range$8.27 - $30.10
Previous CloseN/A
Volume88.39K
Average Volume (3M)561.17K
Market Cap
$379.97M
Enterprise Value$407.96M
Total Cash (Recent Filing)$35.59M
Total Debt (Recent Filing)$63.59M
Price to Earnings (P/E)―
Beta1.91
Next Earnings
Aug 11, 2026EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding29,989,563
10 Day Avg. Volume613,778
30 Day Avg. Volume561,169
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)13.82
Price to Sales (P/S)10.48
P/FCF Ratio-15.84
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue10.04
Enterprise Value/Gross Profit16.25
Enterprise Value/Ebitda-17.04
Forecast
1Y Price Target
$22.00Price Target Upside-19.47% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.98
Revenue Forecast (FY)$53.13M
Bulls Say, Bears Say
Bulls Say
Balance SheetThe balance sheet is solid with over $20M of cash and no debt.
EarningsFunctional Neuro growth was strong at 43% year-over-year.
Partnership DevelopmentsThe partner business recently had significant developments that accelerate $100s of millions of revenue opportunities, with 70%+ gross margins.
Bears Say
Market Entry TimingRevenue opportunities from the partner business are expected to be on the market as early as late 2026.
ClearPoint Neuro News
CLPT FAQ
What was Clearpoint Neuro, Inc.’s price range in the past 12 months?
Clearpoint Neuro, Inc. lowest stock price was $8.27 and its highest was $30.10 in the past 12 months.
What is Clearpoint Neuro, Inc.’s market cap?
Clearpoint Neuro, Inc.’s market cap is $379.97M.
When is Clearpoint Neuro, Inc.’s upcoming earnings report date?
Clearpoint Neuro, Inc.’s upcoming earnings report date is Aug 11, 2026 which is in 70 days.
How were Clearpoint Neuro, Inc.’s earnings last quarter?
Clearpoint Neuro, Inc. released its earnings results on May 13, 2026. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.273 by -$0.047.
Is Clearpoint Neuro, Inc. overvalued?
According to Wall Street analysts Clearpoint Neuro, Inc.’s price is currently Overvalued.
Does Clearpoint Neuro, Inc. pay dividends?
Clearpoint Neuro, Inc. does not currently pay dividends.
What is Clearpoint Neuro, Inc.’s EPS estimate?
Clearpoint Neuro, Inc.’s EPS estimate is -0.29.
How many shares outstanding does Clearpoint Neuro, Inc. have?
Clearpoint Neuro, Inc. has 29,989,563 shares outstanding.
What happened to Clearpoint Neuro, Inc.’s price movement after its last earnings report?
Clearpoint Neuro, Inc. reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.273. Following the earnings report the stock price went up 4.758%.
Which hedge fund is a major shareholder of Clearpoint Neuro, Inc.?
Currently, no hedge funds are holding shares in CLPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ClearPoint Neuro Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.00 (-19.47% Downside)
$22.00 (-19.47% Downside)
Blogger Sentiment
Bullish
CLPT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 21.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $185.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 7.9%
Last 30 Days ▼ 7.9%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.02%
12-Months-Change
Fundamentals
Return on Equity
-140.96%
Trailing 12-Months
Asset Growth
210.66%
Trailing 12-Months
Company Description
Clearpoint Neuro, Inc.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
CLPT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominantly positive commercial and strategic update: record Q1 revenue (+43% YoY), improved gross margin (64%), significant product and regulatory milestones (PRISM expansion, Velocity drill FDA clearance and CE marking), and visible IRRAflow integration progress and synergies. These positives are tempered by meaningful near-term cash reduction and a $8M operational burn in Q1 plus elevated operating expenses (R&D +34%, S&M +75%, G&A +22%) largely tied to growth investments and integration. Management forecasts a return to improved cash consumption as integration completes and reiterated full-year revenue guidance of $52M–$56M. Regulatory uncertainty on the biologics side and temporary OUS distribution transitions introduce timing risk for some programs, while biologics/drug delivery revenue remained essentially flat (+2%) this quarter. Overall, the fundamentals and strategic momentum outweigh the near-term financial and operational headwinds.View all CLPT earnings summariesCLPT Stock 12 Month Forecast
Average Price Target
$22.00
▼(-19.47% Downside)
Technical Analysis
Ownership Overview
3.85% Insiders
9.04% Mutual Funds
13.03% Other Institutional Investors
65.44% Public Companies and
Individual Investors